CTMX financials

CytomX Therapeutics (CTMX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

CTMX income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$76.20M–-$22.36M-$20.37M–
2024$138.10M–$25.00M$31.87M–
2023$101.21M–-$6.48M-$569.00K–
2022$53.16M–-$101.33M-$99.32M–
2021$37.31M–-$116.04M-$115.87M–
2020$68.43M–-$80.54M-$64.82M–